United States· US:68083-101_e47b17c4-e913-43cf-8406-c38e16f5ae36
Adenosine
A adenosine product containing adenosine, registered in United States by Gland Pharma Limited. The same ATC class is registered in 16 of our 19 countries.
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
Where it is registered
Adenosine is registered in 16 of 19 countries.
Countries holding a registration under ATC C01EB10 (adenosine), each read from that country’s own register.
- This record: United States, from FDA National Drug Code directory (United States)
- 8 of them publish a price we can compare per daily dose
Adenosine · ATC C01EB10
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- ADENOSINE
- Manufacturer
- Gland Pharma Limited
- Country
- United States (US)
- ATC code
- C01EB10
- ATC class
- Adenosine
- Defined daily dose
- 15 mg, P
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 27, 2026
Packs & prices · 4
- ndc1168083-101-02
- ndc1168083-101-01
- ndc11680831010110 SYRINGE in 1 CARTON (68083-101-01) / 2 mL in 1 SYRINGE
- ndc11680831010210 SYRINGE in 1 CARTON (68083-101-02) / 4 mL in 1 SYRINGE
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
181 interactions on record for adenosine.
Graded by severity as the source publishes them — 38 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Adenosine · interactions on record
181 records
- 38 severe
- 90 moderate
- 1 minor
- 52 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- DolasetronA04AA04severe
- PapaverinC04AX38severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Adenosine in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomAdenocor 6mg/2ml solution for injection vialsSanofi
- PolandAdenocorDelfarma Sp. z o.o.
- GermanyAdenoscanSanofi-Aventis Deutschland Gmbh
- SpainADENOCOR 6 mg/2 ml SOLUCION INYECTABLESanofi Aventis S.A.
- FranceADENOSCAN 30 mg/10 mL, solution pour perfusionSANOFI WINTHROP INDUSTRIE
- FinlandAdenocorSanofi Oy
- BelgiumAdenocor 6 mg/2 mlSanofi Belgium
- NetherlandsAdenocor, injectievloeistof voor intraveneuze toediening 3 mg/mlSanofi B.V.
Authorised across Europe · EMA
The same active substance is authorised in 23 EEA countries. Names it is sold under:
- Austria · Adenosin Baxter, Adenosin Hikma
- Belgium · Adenocor, Adenosine Fresenius Kabi
- Cyprus · Caden
- Czechia · Adenocor
- Germany · Adenoscan, Adenosin Altamedics
- Denmark · Adenocor, Adenosin Fresenius Kabi
- Estonia · Adenosin Life Medical
- Spain · Adenocor, Adenoscan
- Finland · Adenosin Life Medical, Adenosin Macure
- France · Adenoscan, Adenosine Hikma
- United Kingdom (Northern Ireland) · Adenocor, Adenoscan
- Greece · Adenorythm
- Hungary · Adenocor
- Ireland · Adenocor, Adenosine
- Italy · Adenoscan, Adenosina Hikma
- Lithuania · Adenosine Life Medical
- Luxembourg · Adenocor
- Netherlands · Adenocor, Adenosine Fresenius Kabi
- Norway · Adenosin Life Medical, Adenosin Macure
- Poland · Adenocor
- Portugal · Adenoscan, Adenosina Baxter
- Sweden · Adenosin Life Medical, Adenosin Macure
- Slovakia · Adenocor
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/bd9388f7-0bcf-443a-aa82-9607f8ed3c4d GET /v1/drugs/bd9388f7-0bcf-443a-aa82-9607f8ed3c4d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "INTRAVENOUS",
"source": "ndc",
"strength": "3",
"substance": "ADENOSINE",
"productndc": "68083-101",
"dosage_form": "INJECTION",
"dea_schedule": null,
"strength_unit": "mg/mL",
"application_number": "ANDA077283",
"marketing_category": "ANDA"
}See everything about adenosine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.